Related Experiment Videos
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial
Hisatomi Arima1, John Chalmers, Mark Woodward
1The George Institute for International Health, University of Sydney, Sydney, NSW, Australia.
Insights
Lowering blood pressure (BP) in patients with cerebrovascular disease is beneficial. Intensive BP reduction appears to further decrease stroke recurrence risk without increasing serious complications.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Clinical Trials
Background:
- Patients with a history of cerebrovascular disease are at high risk for recurrent events.
- Blood pressure management is a cornerstone of secondary prevention in these patients.
- The optimal blood pressure target for minimizing recurrent stroke risk remains an area of investigation.
Purpose of the Study:
- To determine the optimal blood pressure (BP) level for patients with a history of cerebrovascular disease.
- To investigate the relationship between baseline and achieved BP levels and the risk of recurrent stroke.
Main Methods:
- Post hoc analyses of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS), a randomized, placebo-controlled trial involving 6105 patients.
- Investigated the effects of randomized treatment on recurrent stroke based on baseline BP levels.
- Conducted an observational analysis of achieved follow-up BP levels and recurrent stroke risk.
Main Results:
- BP lowering with combination therapy showed similar risk reductions across baseline BP categories.
- Achieved follow-up BP levels demonstrated that the lowest stroke recurrence risk was associated with the lowest BP levels (median 112/72 mmHg).
- Minor side-effects increased with lower BP, but serious complications did not increase.
Conclusions:
- No evidence of a J-curve relationship between BP level and stroke risk in patients with cerebrovascular disease.
- Intensive BP lowering is expected to yield greater risk reductions in this patient population.
- Further research may refine BP targets for optimal stroke prevention.
Objective:
To explore the likely optimum blood pressure (BP) level for patients with a history of cerebrovascular disease.
Methods:
The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) was a randomized, placebo-controlled trial that established the beneficial effects of BP lowering in 6105 patients with cerebrovascular disease. The present study comprises two series of post hoc analyses. The first was designed to investigate the effects of randomized treatment on recurrent stroke by baseline BP levels, and the second was a corresponding observational analysis investigating the association between achieved follow-up BP levels and recurrent stroke risk.
Results:
Analyses of the randomized treatment comparisons showed that BP lowering with combination therapy produced similar risk reductions in each of four subgroups defined by baseline BP of less than 120, 120-139, 140-159, and 160 mmHg or greater (P homogeneity = 0.5). The effects of single-drug therapy were also comparable across these subgroups (P homogeneity = 0.2), but consistently greater benefits were observed with combination compared to single-drug therapy. The analyses of achieved follow-up BP showed that the lowest risk of recurrence was among the one-quarter of participants with the lowest follow-up BP levels (median 112/72 mmHg), and that risks rose progressively with higher follow-up BP levels. Minor side-effects were progressively more common at lower BP levels (P homogeneity = 0.04), but there was no excess of serious complications (all P homogeneity > 0.2).
Conclusion:
These analyses provide no evidence of a J-curve relationship between BP level and stroke risk among patients with cerebrovascular disease, and identify no patient group among whom more intensive BP lowering would not be expected to produce greater risk reductions.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Atherosclerosis III: Management
Hypertension V: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Hypertension III: Clinical Manifestations and Diagnostic Studies
Errors occurring during blood pressure monitoring
Several factors...